Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system to fight tumors

By Heather McPherson,  Newser User

Posted Mar 30, 2007 11:20 AM CDT
Email

(Newser) – A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a patient's own white blood cells to fight tumors—to hit the market.

Provenge's success bucks the field's record of “disappointment and controversy,” notes a researcher, though it may not prove to be a home run.  While it prolonged patients lives an average of 4.5 months, it didn't eradicate tumors. It could be approved by the FDA as early as May.

Tony Glavan, 45, received injections in his legs as part of a new clinical trial of a vaccine researchers hope will trigger his immune system to destroy cancer cells. Making the injection is Pam Mader
Tony Glavan, 45, received injections in his legs as part of a new clinical trial of a vaccine researchers hope will trigger his immune system to destroy cancer cells. Making the injection is Pam Mader...   (KRT Photos)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

Dendreon Announces Plans to Submit Application for FDA Approval
Prostate Cancer Research Institute

FDA panel recommends approval for Dendreon's Provenge
Pharma Times

Dendreon Decision Could Mean FDA Shift
Forbes

 
cancer • FDA • health • prostate cancer • cancer vaccine • vaccine • Provenge

More Newser Stories

Conservatives Wield FDA Data on HPV Vaccine

Vaccine May Not Prevent Cervical Cancer

Consumer Reports Warns of Arsenic in Fruit Juices

FDA Approves Vaccine for Prostate Cancer

Breast Cancer Vaccine Passes Safety Test
NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne